StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
603385.SS$5.82-3.48%
Fair $5.82+0.0%

603385.SS

Huida Sanitary Ware Co.,Ltd

Industrials / Building Products & EquipmentShanghai

$5.82

-0.21 (-3.48%)

Fairly Valued+0.0%Fair Value $5.82Fund rank 32/100 · Data gapFallback financials|
SA 24/D
F-Score: 3/9
Declining RevenueLow Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 25% · confianza 25%

FCF escenarios

weak_data · normalized FCF $181.0M · quality 66.0/100

Data gap 32/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 55/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

24/100

D

Piotroski

3/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 2unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. Revenue has declined for 2 consecutive years ROE is -5.3%, below the 5% threshold
Thesis & Journal · 603385.SSLocal privado en este navegador · Huida Sanitary Ware Co.,Ltd
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$2.2B

P/E

N/A

•

EV/EBITDA

N/A

•

ROE

-5.3%

↓

Gross Margin

24.3%

↓

Debt/Equity

0.02

↓
52-Week Range$6
$6$8

TradingView lightweight chart

603385.SS price, volumen y niveles de valoración

Último $5.820Periodo -64.0%
Fair value: $5.820

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

-4.9%

FCF CAGR

-21.1%

FCF margin

6.1%

FCF / Net income

-0.95x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $2.94B · net income $-189.8M · FCF $181.0M

2022-FY → 2025-FY

Gross margin

24.3%-0.5% pts

Operating margin

-2.9%-7.5% pts

Net margin

-6.4%-10.2% pts

FCF margin

6.1%-4.7% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$2.94B$2.94B$3.46B$3.60B$3.42B
Net Income$-189.8M$-189.8M$138.9M$-196.6M$128.2M
EBITDA$-11.9M$-11.9M$393.7M$32.6M$368.7M
EPS——0.36-0.510.33
Gross Margin24.3%24.3%26.8%24.7%24.8%
Operating Margin-2.9%-2.9%4.1%4.0%4.6%
Net Margin-6.4%-6.4%4.0%-5.5%3.7%
Balance Sheet
Debt/Equity0.020.020.040.140.13
Current Ratio2.482.48———
Cash Flow
Free Cash Flow$181.0M$181.0M$140.2M$464.5M$369.3M
Returns
ROE-5.3%-5.3%3.7%-5.4%3.3%
Valuation
P/E——16.72—22.79
EV/EBITDA——5.52106.108.62
P/B0.620.620.610.870.75
Growth & Yield
Revenue Growth-14.9%-14.9%-3.9%5.4%—
EPS Growth——170.6%-254.5%—
Dividend Yield1.8%1.8%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -8.1%

Total return

-8.1%

Start / end P/E

n/dx → n/dx

EPS bridge

0.36 → n/d

Residual

-9.9%

EPS growthn/d
Multiple reratingn/d
Dividend+1.8%
Residual / FX / buybacks / cross-term-9.9%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.